HealthTronics Inc. has withdrawn an unsolicited $26.9 million cash buyout offer for Irvine device maker Endocare Inc.
Endocare rejected Austin, Texas-based HealthTronics’ bid last month, saying the bid undervalued the company.
Last week, HealthTronics said its bid for Endocare still stood.
James Whittenburg, HealthTronics’ chief executive, said that his company believes it is prudent to withdraw the bid because it’s “had no insight into Endocare’s performance since it reported second-quarter earnings” and that the company’s received no further dialogue from Endocare on the offer.
HealthTronics’ offer for Endocare was a 20% premium over the company’s closing price on Aug. 8, when it made the bid after the market closed that day.
HealthTronics, a urology product maker, wanted Endocare in order to expand its product offerings. Endocare focuses on cryoablation-based procedures, which use ice in surgeries to freeze and destroy cells and tissues.
